Published in
Esmo Open, Esmo Open, (3), p. A224, 2018
DOI: 10.1136/esmoopen-2018-eacr25.529
Esmo Open, Esmo Open, (3), p. A223, 2018
DOI: 10.1136/esmoopen-2018-eacr25.528
Links
Tools
PO-513 Using mapk and pi3k signalling to predict patient outcome in resectable stage iiib/c melanoma patients neoadjuvantly treated with dafrafenib and trameitinib
Journal article published in 2018 by
H. Lee,
A. Menzies,
M. Carlino 
,
R. Saw,
H. Niwa,
J. Thompson,
A. Guminski,
R. Scolyer,
D. Ohota,
J. Wilmott,
K. Jun,
H. Kazuyoshi,
G. Long
,
R. Saw,
H. Niwa,
J. Thompson,
A. Guminski,
R. Scolyer,
D. Ohota,
J. Wilmott,
K. Jun,
H. Kazuyoshi,
G. Long
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 